Company Profiles

driven by the PitchBook Platform

Asceneuron

Description

Provider of therapeutics treatment for Alzheimer's disease. The company develops therapeutics for orphan tauopathies and improved symptomatic drugs for Alzheimer's disease.

2012

Founded

PRIVATE

Status

1-10

Employees

Grant

Latest Deal Type

$37.1M

Total Amount Raised

8

Investors

Description

Provider of therapeutics treatment for Alzheimer's disease. The company develops therapeutics for orphan tauopathies and improved symptomatic drugs for Alzheimer's disease.

Website:

www.asceneuron.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Other Healthcare Services

Primary Office

EPFL Innovation Park Bâtiment B 1015 LausanneSwitzerland
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Asceneuron's full profile, request a free trial.

Asceneuron Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Asceneuron Investors (8)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Alzheimers Drug Discovery FoundationOther000 0000000 0000
EPFL Innovation ParkAccelerator/Incubator000 0000000 0000
Johnson & Johnson Innovation - JJDCCorporate Venture CapitalMinority000 0000000 0000
Kurma PartnersVenture CapitalMinority000 0000000 0000
Merck VenturesCorporate Venture CapitalMinority000 0000000 0000
Alzheimers Drug Discovery Foundation Other
EPFL Innovation Park Accelerator/Incubator
Johnson & Johnson Innovation - JJDC Corporate Venture Capital
Kurma Partners Venture Capital
Merck Ventures Corporate Venture Capital

Asceneuron Executive Team (5)

NameTitleBoard
Seat
Contact
Info
Dirk Beher Ph.DChief Executive Officer, Board Member and Co-Founder
Christoph Wiessner Ph.DChief Operating Officer & Vice President, Research & Development, Co-Founder
Anna Quattropani Ph.DHead, Medicinal Chemistry
Bruno PermanneHead, vitro pharmacology
Michael RyanChief Medical Officer
Dirk Beher Ph.D Chief Executive Officer, Board Member and Co-Founder
Christoph Wiessner Ph.D Chief Operating Officer & Vice President, Research & Development, Co-Founder
Anna Quattropani Ph.D Head, Medicinal Chemistry
Bruno Permanne Head, vitro pharmacology
Michael Ryan Chief Medical Officer

Asceneuron Board Members (9)

NameRepresentingRoleSinceContact
Info
Deborah Harland Ph.DSR OnePartner000 0000
Dirk Beher Ph.DAsceneuronChief Executive Officer, Board Member and Co-Founder000 0000
Franz Hefti Ph.DSelfBoard Member000 0000
Hakan Goker Ph.DMerck VenturesSenior Investment Director000 0000
Hans Schikan Ph.DSelfChairman000 0000
Deborah Harland Ph.D Partner SR One
Dirk Beher Ph.D Chief Executive Officer, Board Member and Co-Founder Asceneuron
Franz Hefti Ph.D Board Member Self
Hakan Goker Ph.D Senior Investment Director Merck Ventures
Hans Schikan Ph.D Chairman Self
Request full access to PitchBook